Medtronic won FDA regulatory approval and is releasing in the U.S. its Resolute Onyx drug-eluting (zotarolimus) stent. The device is based on the company’s Resolute Integrity device and is available in 4.5 mm and 5.0 mm diameters for patients with larger coronary arteries. It is designed for transradial delivery via a 5 French catheter.
The (Read more...)